“Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and Or BCL-2 Inhibitor Failure”. Canadian Hematology Today, vol. 3, no. 2, June 2024, pp. 49–53, https://doi.org/10.58931/cht.2024.3255.